The Cancer Letter

Inside information on cancer research and drug development

In Brief

House agriculture spending bill provisions could jeopardize efforts to reduce tobacco-related cancers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The U.S. House of Representatives Committee on Appropriations’ Subcommittee on Agriculture, Rural Development, and Food and Drug Administration is scheduled to consider an appropriations bill to fund the Department of Agriculture, FDA, and other related agencies for FY2024. The bill includes several provisions that would keep FDA from fulfilling its duty to protect public health and threaten its efforts to combat the harmful impacts of tobacco. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

House Energy and Commerce Committee Democratic leaders urge FDA to advance clinical trial diversity efforts

Energy and Commerce Committee Health Subcommittee Ranking Member Rep. Anna G. Eshoo (D-CA), Ranking Member Rep. Frank Pallone, Jr. (D-NJ), and Oversight and Investigations Subcommittee Ranking Member Rep. Kathy Castor (D-FL) wrote to FDA Commissioner Robert M. Califf to urge the agency to move forward with guidance to improve the diversity of populations represented in clinical trials.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account